TrialHuman vaccines & immunotherapeutics2019

Immunogenicity and safety of a meningococcal serogroups A and C tetanus toxoid conjugate vaccine (MenAC-TT): two immune schedules in toddles aged 12-23 months in China.

Jialei Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.